Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

January 9, 2021

Carbapenem-Resistant Gram Negative Bacilli Are Predominantly Multidrug or Pan-Drug Resistant

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Priya KannianChandran Priya
January 8, 2021
Open Access

Genomic Epidemiology and Evolution of Escherichia coli in Wild Animals in Mexico

MSphere
Robert MurphyDanesh Moradigaravand
January 8, 2021
Open Access

Luminescent Amphiphilic Aminoglycoside Probes for Study of Transfection

Chembiochem : a European Journal of Chemical Biology
Alexander ZimmermannJens Voskuhl
January 11, 2021

Characterization of EGR-1 Expression in the Auditory Cortex Following Kanamycin-Induced Hearing Loss in Mice

Journal of Molecular Neuroscience : MN
Man WangHaibo Wang
January 12, 2021
Open Access

Multidrug Resistance in Enterococci Isolated From Wild Pampas Foxes (Lycalopex gymnocercus ) and Geoffroy's Cats (Leopardus geoffroyi ) in the Brazilian Pampa Biome

Frontiers in Veterinary Science
Gabriella Oliveira de AraujoAna Paula Guedes Frazzon
January 8, 2021
Open Access

Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria

Journal of Enzyme Inhibition and Medicinal Chemistry
Zainab M ElsayedEman R Mohammed
January 8, 2021
Open Access

The noncoding RNA BC200 associates with polysomes to positively regulate mRNA translation in tumor cells

The Journal of Biological Chemistry
Evan P BooySean A McKenna
January 12, 2021

The antimicrobial peptide Gad-1 clears Pseudomonas aeruginosa biofilms under cystic fibrosis conditions

Chembiochem : a European Journal of Chemical Biology
Jasmin Portelinha, Alfredo Milton Angeles-Boza
January 11, 2021
Open Access

Risk factors, antimicrobial susceptibility pattern and patient outcomes of Pseudomonas aeruginosa infection: A matched case-control study

Journal of Infection and Public Health
Fatima A AlhussainMotasim Badri

Sign up to follow this feed and discover related papers.

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

© 2021 Meta ULC. All rights reserved
/feed-previews/aminoglycosides-asm/b289b91b-a625-4d61-b580-2b64220fd74e